ABSTRACT NUMBER: ESOC2026A1463 STATIN THERAPY AND STROKE RISK IN PATIENTS WITH HYPERCHOLESTEROLAEMIA: A POPULATION-BASED LONGITUDINAL STUDY USING ELECTRONIC HEALTH RECORDSIN SOUTH LONDON
Marc Delord, Abdel Douiri · 2026
Read ABSTRACT NUMBER: ESOC2026A1463 STATIN THERAPY AND STROKE RISK IN PATIENTS WITH HYPERCHOLESTEROLAEMIA: A POPULATION-BASED LONGITUDINAL STUDY USING ELECTRONIC HEALTH RECORDSIN SOUTH LONDON by Marc Delord, Abdel Douiri (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13145660.txt.
Description
Marc Delord and Abdel Douiri mine south London health records to ask two questions: do statins cut stroke risk in people with high cholesterol, and who gets left unprescribed? Their 2026 study covers 166,124 patients with the condition across 41 practices, from records spanning 2005 to 2021. Only a third had a statin prescription on file.
Adjusted models tied statin use to a 26 percent lower stroke hazard, in patients with and without prior heart disease. Yet prescribing was uneven: women had markedly lower odds of receiving a statin, and Black patients lower odds still. The conference abstract thus pairs a benefit with a gap. Its authors argue the protection is real but the reach is unfair, and closing the prescribing gap is itself a stroke intervention.
Catalog record
| CREATOR | Marc Delord, Abdel Douiri |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |